Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Pindolol Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Indications
Dosages
Interactions
Precautions
Contraindications
Adverse Reactions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Acarbose

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Adrenaline

  • Adverse Effect: Hypertension, bradycardia, resistance to Adrenaline in anaphylaxis  
  • Clinical Management: Concurrent use should be avoided if possible. However, if used concurrently, monitor blood pressure carefully. If a nonselective Pindolol causes resistance to Adrenaline in anaphylactic shock, glucagon may be effective in a dose of 1 mg or more intravenously every five minutes.

    Amiodarone

  • Adverse Effect: hypotension, bradycardia, or cardiac arrest  
  • Clinical Management: Monitor cardiac function carefully. Amiodarone should be used with caution in patients receiving beta blockers particularly if there is suspicion of underlying dysfunction of the sinus node, such as bradycardia or sick sinus syndrome, or if there is partial AV block.

    Amlodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Benidipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Celecoxib

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Chlorpropamide

  • Adverse Effect: Hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Clonidine

  • Adverse Effect: exaggerated clonidine withdrawal response (acute hypertension)  
  • Clinical Management: When clonidine is to be withdrawn from concomitant therapy with a beta blocker, discontinue the beta blocker first, and monitor blood pressure carefully. Labetalol (alph/beta blocker) or alpha blockers (eg, prazosin, doxazosin) may prevent rebound hypertension.

    Diclofenac Preps

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Digoxin

  • Adverse Effect: AV block and possible digoxin toxicity  
  • Clinical Management: When beta blockers and digoxin are to be given concomitantly, carefully monitor ECG and digoxin serum concentrations. Adjust doses accordingly.

    Diltiazem

  • Adverse Effect: hypotension, bradycardia, AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure. A dosage adjustment for hepatically metabolized beta blockers may be required.

    Doxazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Felodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Flunarizine

  • Adverse Effect: hypotension, bradycardia, and AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Flurbiprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Glibenclamide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects.Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Gliclazide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glimepiride

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glipizide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Guar Gum

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ibuprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Indomethacin

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Insulin Lispro

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ketoprofen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketorolac

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Lacidipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Lidoflazine

  • Adverse Effect: hypotension, bradycardia, and AV conduction disturbances  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Mefenamic Acid

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Meloxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Metformin

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Methyldopa

  • Adverse Effect: exaggerated hypertensive response, tachycardia, or arrhythmias during physiologic stress or exposure to exogenous catecholamines  
  • Clinical Management: Monitor blood pressure carefully during concurrent therapy, especially during excessive physiologic stress or use of exogenous catecholamines such as phenylpropanolamine.

    Nabumetone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Naproxen

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nifedipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nimesulide

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nimodipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nitrendipine

  • Adverse Effect: hypotension and/or bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Oxyphenbutazone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenacetin

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenylbutazone

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Piroxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Prazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Prazosin - BPH

  • Adverse Effect: An exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Procainamide

  • Adverse Effect: an increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest)  
  • Clinical Management: The concurrent administration of Procainamide is not recommended. The Procainamide should be withheld for at least three half-lives prior to dosing.

    Ritodrine

  • Adverse Effect: potential interference with tocolytic action of ritodrine  
  • Clinical Management: It is possible to successfully treat a patient with both a beta blocker and a beta mimetic if an appropriate dosage is found and the clinical response is monitored.

    Tenoxicam

  • Adverse Effect: Decreased antihypertensive effect  
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Terazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Terazosin - BPH

  • Adverse Effect: An exaggerated hypotensive response to the first dose of the alpha blocker  
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Thioridazine

  • Adverse Effect: Increased levels of both pindolol and thioridazine  
  • Clinical Management: Monitor the thioridazine level and watch the patient for signs and symptoms of thioridazine toxicity.

    Tolbutamide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension  
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Verapamil

  • Adverse Effect: hypotension, bradycardia  
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure
  • Penicillamine
    Penicillin G Benzathine
    Penicillin G Potassium
    Penicillin G Procaine
    Penicillin V Potassium
    Pentamidine Isethionate
    Phenobarbital
    Phenylephrine Hydrochloride
    Phenytion
    Physostigmine Salicylate
    Pilocarpine Hydrochloride
    Piperacillin Sodium
    Polysaccharide Iron Complex
    Potassium Iodide
    Potassium Salts
    Prazosin Hydrochloride
    Prednisolone
    Prednisolone Acetate
    Prednisone
    Primaquine Phosphate
    Primidone
    Probenecid
    Procainamide Hydrochloride
    Promethazine Hydrochloride
    Propranolol Hydrochloride
    Propylthiouracil
    Protamine Sulfate
    Pseudoephedrine Hydrochloride
    Pyrantel Pamoate
    Pyridoxine Hydrochloride
    Paclitaxel
    Pamidronate
    Pancuronium
    Pantoprazole
    Paracetamol
    Pas
    Pefloxacin
    Pefloxacin - Ocular
    Penfluridol
    Penicillin V Phenoxymethyl
    Pentaerythritol Tetranitrate
    Pentazocine
    Pentoxyfylline
    Perindopril
    Permethrin
    Pethidine
    Phenacetin
    Phenazopyridine
    Phenformin
    Phenindione
    Pheniramine Maleate
    Phenobarbitone
    Phenophthalein
    Phenoxybenzamine
    Phenylbutazone
    Phenylephrine
    Phytoestrogens
    Pilocarpine
    Pimozide
    Pindolol
    Pioglitazone
    Pipecuronium
    Pipenzolate Methyl Br - Antispas
    Piperacillin
    Piperazine
    Piracetam
    Piribedil
    Piroxicam
    Pneumococcal vaccine
    Polidocanol
    Polymyxin B - Ocular
    Polymyxin-B
    Potassium citrate + citric acid
    Povidone Iodine
    Povidone Iodine - VU
    Pralidoxime
    Pravastatin sodium
    Praziquantel
    Prazosin
    Prazosin - BPH
    Prednisolone - Topical
    Prednisolone - resp
    Primaquine
    Procainamide
    Procaine Penicillin
    Prochlorperazine
    Procyclidine
    Progesterone
    Proguanil
    Promethazine
    Propantheline Br
    Propantheline Br - Antispas
    Propofol
    Propranolol
    Psoralen
    Pyrazinamide
    Pyridostigmine
    Pyrimethamine
    Pyritinol
     
    Disclaimer